Dhanush Amarasekara

Mr. Dhanush Amarasekara

Mississippi State University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AIAyyam Y. Ibrahim
Ayyam Y. Ibrahim
NKNathan P. Khaodeuanepheng
Nathan P. Khaodeuanepheng
DADhanush Amarasekara
Dhanush Amarasekara
JCJohn J. Correia
John J. Correia
KLKaren A. Lewis
Karen A. Lewis
SWSteven T Whitten
Steven T Whitten
Protein phase separation is thought to be a primary driving force for the formation of membrane-less organelles, which control a wide range of biological functions from stress response to ribosome biogenesis. Among phase-separating (PS) proteins, many have intrinsically disordered regions (IDRs) that are needed for phase separation to occur. Accurate identification of IDRs that drive phase separation is important for testing the underlying mechanisms of phase separation, identifying biological processes that rely on phase separation, and designing sequences that modulate phase separation. To identify IDRs that drive phase separation, we first curated datasets of folded, ID, and PS ID sequences. We then used these sequence sets to examine how broadly existing amino acid property scales can be used to distinguish between the three classes of protein regions. We found that there are robust property differences between the classes and, consequently, that numerous combinations of amino acid property scales can be used to make robust predictions of protein phase separation. This result indicates that multiple, redundant mechanisms contribute to the formation of phase-separated droplets from IDRs. The top-performing scales were used to further optimize our previously developed predictor of PS IDRs, ParSe. We then modified ParSe to account for interactions between amino acids and obtained reasonable predictive power for mutations that have been designed to test the role of amino acid interactions in driving protein phase separation. Collectively, our findings provide further insight into the classification of IDRs and the elements involved in protein phase separation.

24 September 2021 in Molecules
Verified
Journal Article
Open access
PDF file
YMYasiru Randika Mahamarakkalage
Yasiru Randika Mahamarakkalage
JXJoanna Xiuzhu Xu
Joanna Xiuzhu Xu
DADhanush Amarasekara
Dhanush Amarasekara
AHAlex C. Hughes
Alex C. Hughes
Ibraheem AbboodIbraheem Abbood
Ibraheem Abbood
NFNicholas C Fitzkee
Nicholas C Fitzkee
Polyethylene glycol (PEG) surface conjugations are widely employed to render passivating properties to nanoparticles in biological applications. The benefits of surface passivation by PEG are reduced protein adsorption, diminished non-specific interactions, and improvement in pharmacokinetics. However, the limitations of PEG passivation remain an active area of research, and recent examples from the literature demonstrate how PEG passivation can fail. Here, we study the adsorption amount of biomolecules to PEGylated gold nanoparticles (AuNPs), focusing on how different protein properties influence binding. The AuNPs are PEGylated with three different sizes of conjugated PEG chains, and we examine interactions with proteins of different sizes, charges, and surface cysteine content. The experiments are carried out in vitro at physiologically relevant timescales to obtain the adsorption amounts and rates of each biomolecule on AuNP-PEGs of varying compositions. Our findings are relevant in understanding how protein size and the surface cysteine content affect binding, and our work reveals that cysteine residues can dramatically increase adsorption rates on PEGylated AuNPs. Moreover, shorter chain PEG molecules passivate the AuNP surface more effectively against all protein types.

6 March 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
LTLuke Jackson Tucker
Luke Jackson Tucker
Christine GrantChristine Grant
Christine Grant
Malley GautreauxMalley Gautreaux
Malley Gautreaux
DADhanush Amarasekara
Dhanush Amarasekara
NFNicholas C Fitzkee
Nicholas C Fitzkee
LPLauren B. Priddy
Lauren B. Priddy
Thermosensitive chitosan hydrogels—renewable, biocompatible materials—have many applications as injectable biomaterials for localized drug delivery in the treatment of a variety of diseases. To combat infections such as Staphylococcus aureus osteomyelitis, localized antibiotic delivery would allow for higher doses at the site of infection without the risks associated with traditional antibiotic regimens. Fosfomycin, a small antibiotic in its own class, was loaded into a chitosan hydrogel system with varied beta-glycerol phosphate (β-GP) and fosfomycin (FOS) concentrations. The purpose of this study was to elucidate the interactions between FOS and chitosan hydrogel. The Kirby Bauer assay revealed an unexpected concentration-dependent inhibition of S. aureus, with reduced efficacy at the high FOS concentration but only at the low β-GP concentration. No effect of FOS concentration was observed for the planktonic assay. Rheological testing revealed that increasing β-GP concentration increased the storage modulus while decreasing gelation temperature. NMR showed that FOS was removed from the liquid portion of the hydrogel by reaction over 12 h. SEM and FTIR confirmed gels degraded and released organophosphates over 5 days. This work provides insight into the physicochemical interactions between fosfomycin and chitosan hydrogel systems and informs selection of biomaterial components for improving infection treatment.

18 January 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
DADhanush Amarasekara
Dhanush Amarasekara
CKChathuri S. Kariyawasam
Chathuri S. Kariyawasam
MHMadison A. Hejny
Madison A. Hejny
VTVeeresh B. Torgall
Veeresh B. Torgall
TWThomas A. Werfel
Thomas A. Werfel
NFNicholas C Fitzkee
Nicholas C Fitzkee

21 January 2024 in Small
Verified
Journal Article
Closed access
RSRadha P. Somarathne
Radha P. Somarathne
DADhanush Amarasekara
Dhanush Amarasekara
CKChathuri S. Kariyawasam
Chathuri S. Kariyawasam
HRHarley A. Robertson
Harley A. Robertson
RMRailey Mayatt
Railey Mayatt
NFNicholas C Fitzkee
Nicholas C Fitzkee

20 March 2026 in ACS Nano Medicine
Verified
Journal Article
Closed access
TSTanveer Shaikh
Tanveer Shaikh
DADhanush Amarasekara
Dhanush Amarasekara
KHKenneth Hulugalla
Kenneth Hulugalla
VTVeeresh B. Toragall
Veeresh B. Toragall
RGRyan J. Garrigues
Ryan J. Garrigues
NFNicholas C Fitzkee
Nicholas C Fitzkee